Job Objective:
One sentence summary of the main objective of the job, the most important activities and the means and guidelines to obtain the objectives.
Lead and manage the EHS function at the manufacturing site to ensure full compliance with legal, corporate, and industry-specific standards, and to promote a proactive safety culture through risk assessments, audits, and continuous improvement initiatives.
Environment
Internal and external interactions i.e.: with other departments/divisions, international scope, providers, customers)
Internal: Operations, Quality, Maintenance, HR, Engineering, Compliance
External: Regulatory Authorities, Third-Party Auditors, Contractors, Suppliers
Key responsibility
Develop and implement site-specific EHS programs
Lead audits and inspections, ensuring corrective action implementation
Conduct risk assessments and HAZOP studies
Monitor legal compliance and maintain permits/licenses
Drive sustainability and environmental initiatives
Lead incident investigations and root cause analyses
Serve as EHS liaison with regulatory bodies
Academic experience required
Bachelors degree in Environmental Engineering, Occupational Health & Safety, Industrial Engineering or related field. NEBOSH Certified is Must.
Professional Experience Required
8 to 10 years in EHS roles within the pharmaceutical or process industry, with at least 3 years in a managerial role.
Lead ISO 45001,14001 certificates
Computing Skills
MS Office, EHS Management Systems (e.g., Enablon, Intelex)
Personal Skills
Leadership, decision-making, problem-solving, communication, team management
Languages
Fluent in English and Arabic
Grifols Egypt for plasma derivatives is a joint-venture (JV) company between the Egyptian Government, through the National Service Projects Organization (NSPO) and Grifols, the global leader in plasma medicines with more than 110 years of contribution to improving the health and well-being of people.
This joint venture is the first of its kind in the plasma industry and the first-ever Egyptian source member of the Plasma Protein Therapeutics Association (PPTA). GEPD is a groundbreaking global public-private alliance that will benefit the entire region.
GEPD is committed to developing the plasma medicines market and achieving self-sufficiency in these critical therapies, which is crucial for the Egyptian healthcare system.
We are combining the expertise of both shareholders to build and operate 20 plasma donation centers throughout Egypt, along with manufacturing facilities including fractionation, purification, and fill-and-finish plants with a processing capacity of up to 1 million liters of plasma annually that can double in the future.
The new manufacturing facility will include a plasma warehouse and a testing laboratory. It will occupy 105,000 square meters strategically located in the administrative capital’s medical city, adjoining various healthcare institutions.
